The research team at the College of Science at the University of Basrah, consisting of Dr. Ferdous Nouri Jaafar, Dr. Muhammad Latif Ali from the Department of Biology, and Dr. Niran Jassim Al-Salihi from the Department of Chemistry, obtained a patent for isolating the compound
1-(indolin-3-yl)Propane-1,2,3-triol
diagnosed for the first time in the world and isolated from the secondary metabolite extract of T.harzianum isolate, which was recorded for the first time in the world and included in the global gene bank under the name T.harzianum MarinoFaw.
The patent included the use of a number of advanced techniques in chemical diagnosis of the compound isolated from the fungal extract, as a number of life tests were conducted on the diagnosed compound, such as anti-bacterial, anti-fungal and anti-cancer efficacy. Yeasts and fungi isolated from various fungal infections. The compound showed varying inhibitory activity against the tested pathogenic bacteria strains and showed high anti-fungal activity against a number of yeasts and fungi isolated from various fungal infections.
The effectiveness of the compound was also tested against Hela cell line cervical cancer cells and it was found that it has activity against cancer cells at a concentration of 62.5 mcg/ml and at the higher concentrations.
